Neurodegeneration in Multiple Sclerosis
In multiple sclerosis (MS), conventional magnetic resonance imaging (cMRI) has proved to be a valuable tool to increase diagnostic reliability and to monitor the efficacy of experimental treatment. However, cMRI has limited specificity and accuracy as to the most disabling aspects of the MS patholog...
Συγγραφή απο Οργανισμό/Αρχή: | |
---|---|
Άλλοι συγγραφείς: | , , |
Μορφή: | Ηλεκτρονική πηγή Ηλ. βιβλίο |
Γλώσσα: | English |
Έκδοση: |
Milano :
Springer Milan,
2007.
|
Σειρά: | Topics in Neuroscience
|
Θέματα: | |
Διαθέσιμο Online: | Full Text via HEAL-Link |
Πίνακας περιεχομένων:
- Background
- Neuropathological Advances in Multiple Sclerosis
- Neurophysiology
- MRI Techniques to Assess Neurodegeneration
- Atrophy
- T1 Black Holes and Gray Matter Damage
- Magnetization Transfer Imaging
- Perfusion MR I
- Diffusion-Weighted Imaging
- Proton MR Spectroscopy
- Functional MRI
- Evaluation of MRI Outcomes
- Validation of MRI Surrogates
- Defining Responders and Non-responders
- Predictive Models in Multimodal Imaging
- Lessons from Other Neurodegenerative Diseases
- Alzheimer’s Disease
- Other Neurodegenerative Conditions
- Incorporation of Other Biomarkers
- Designing MS Trials for Neurodegeneration
- Critical Review of Existing Trials
- Design for the Next Trials of Neurodegeneration.